Cited by 162

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Expression of the transcription factor PU.1 induces the generation of microglia-like cells in human cortical organoids

Cakir, Bilal, Tanaka, Yoshiaki, Kiral, Ferdi Ridvan, Xiang, Yangfei, Dagliyan, Onur, Wang, Juan, Lee, Maria, Greaney, Allison M., Yang, Woo Sub, duBoulay, Catherine, Kural, Mehmet Hamdi, Patterson, Benjamin, Zhong, Mei, Kim, Jonghun, Bai, Yalai, Min, Wang, Niklason, Laura E., Patra, Prabir, Park, In-Hyun·2022·Nature Communications

Abstract

Microglia play a role in the emergence and preservation of a healthy brain microenvironment. Dysfunction of microglia has been associated with neurodevelopmental and neurodegenerative disorders. Investigating the function of human microglia in health and disease has been challenging due to the limited models of the human brain available. Here, we develop a method to generate functional microglia in human cortical organoids (hCOs) from human embryonic stem cells (hESCs). We apply this system to study the role of microglia during inflammation induced by amyloid-β (Aβ). The overexpression of the myeloid-specific transcription factor PU.1 generates microglia-like cells in hCOs, producing mhCOs (microglia-containing hCOs), that we engraft in the mouse brain. Single-cell transcriptomics reveals that mhCOs acquire a microglia cell cluster with an intact complement and chemokine system. Functionally, microglia in mhCOs protect parenchyma from cellular and molecular damage caused by Aβ. Furthermore, in mhCOs, we observed reduced expression of Aβ-induced expression of genes associated with apoptosis, ferroptosis, and Alzheimer’s disease (AD) stage III. Finally, we assess the function of AD-associated genes highly expressed in microglia in response to Aβ using pooled CRISPRi coupled with single-cell RNA sequencing in mhCOs. In summary, we provide a protocol to generate mhCOs that can be used in fundamental and translational studies as a model to investigate the role of microglia in neurodevelopmental and neurodegenerative disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-022-28043-y

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • HNOs that incorporate microglia promote maturation and provide unique advantages as in vitro neuroimmune models.

    “Despite the limitations of organoid-based models, HNOs that incorporate microglia promote maturation97 and provide unique advantages as in vitro neuroimmune models98–103, which are increasingly becoming utilized.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 40

  1. Parkhurst, C. N. et al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 155, 1596–1609 (2013). · DOI · Paper page
  2. Salter, M. W. & Stevens, B. Microglia emerge as central players in brain disease. Nat. Med. 23, 1018–1027 (2017). · DOI · Paper page
  3. Wang, Y. et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer’s disease model. Cell 160, 1061–1071 (2015). · DOI · Paper page
  4. Arlotta, P. Organoids required! A new path to understanding human brain development and disease. Nat. Methods 15, 27–29 (2018). · DOI
  5. Tanaka, Y., Cakir, B., Xiang, Y., Sullivan, G. J. & Park, I. H. Synthetic analyses of single-cell transcriptomes from multiple brain organoids and fetal brain. Cell Rep. 30, 1682–1689e1683 (2020). · DOI
  6. Popova, G. et al. Human microglia states are conserved across experimental models and regulate neural stem cell responses in chimeric organoids. Cell Stem Cell https://doi.org/10.1016/j.stem.2021.08.015 (2021). · DOI
  7. Fagerlund, I. et al. Microglia-like cells promote neuronal functions in cerebral organoids. Cells 11, 124 (2021). · DOI
  8. Ormel, P. R. et al. Microglia innately develop within cerebral organoids. Nat. Commun. 9, 4167 (2018). · DOI
  9. Forsberg, M. et al. Efficient reprogramming of adult neural stem cells to monocytes by ectopic expression of a single gene. Proc. Natl Acad. Sci. USA 107, 14657–14661 (2010). · DOI
  10. Perdiguero, E. G. & Geissmann, F. The development and maintenance of resident macrophages. Nat. Immunol. 17, 2–8 (2016). · DOI
  11. Xiang, Y. et al. Fusion of regionally specified hPSC-derived organoids models human brain development and interneuron migration. Cell Stem Cell 21, 383–398e387 (2017). · DOI
  12. Cakir, B. et al. Engineering of human brain organoids with a functional vascular-like system. Nat. Methods https://doi.org/10.1038/s41592-019-0586-5 (2019). · DOI
  13. Guttikonda, S. R. et al. Fully defined human pluripotent stem cell-derived microglia and tri-culture system model C3 production in Alzheimer’s disease. Nat. Neurosci. 24, 343–354 (2021). · DOI
  14. Xiang, Y. et al. hESC-derived thalamic organoids form reciprocal projections when fused with cortical organoids. Cell Stem Cell 24, 487–497 (2019). e487. · DOI · Paper page
  15. Darmanis, S. et al. A survey of human brain transcriptome diversity at the single cell level. Proc. Natl Acad. Sci. USA 112, 7285–7290 (2015). · DOI · Paper page
  16. Bhaduri, A. et al. Cell stress in cortical organoids impairs molecular subtype specification. Nature 578, 142–148 (2020). · DOI · Paper page
  17. Svoboda, D. S. et al. Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain. Proc. Natl Acad. Sci. USA 116, 25293–25303 (2019). · DOI
  18. Pasca, S. P. The rise of three-dimensional human brain cultures. Nature 553, 437–445 (2018). · DOI
  19. Kracht, L. et al. Human fetal microglia acquire homeostatic immune-sensing properties early in development. Science 369, 530–537 (2020). · DOI
  20. Condello, C., Yuan, P., Schain, A. & Grutzendler, J. Microglia constitute a barrier that prevents neurotoxic protofibrillar A beta 42 hotspots around plaques. Nat. Commun. 6, ARTN 6176 10.1038/ncomms7176 (2015). · DOI · Paper page
  21. Barinaga, M. Is apoptosis key in Alzheimer’s disease? Science 281, 1303–1304 (1998). · DOI
  22. Wyss-Coray, T. et al. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer’s disease. Nature 389, 603–606 (1997). · DOI · Paper page
  23. Abdalkader, M., Lampinen, R., Kanninen, K. M., Malm, T. M. & Liddell, J. R. Targeting Nrf2 to suppress ferroptosis and mitochondrial dysfunction in neurodegeneration. Front. Neurosci. 12, 466 (2018). · DOI
  24. Malhotra, D. et al. Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis. Nucleic Acids Res. 38, 5718–5734 (2010). · DOI
  25. Efthymiou, A. G. & Goate, A. M. Late onset Alzheimer’s disease genetics implicates microglial pathways in disease risk. Mol. Neurodegener. 12, 43 (2017). · DOI · Paper page
  26. Hollingworth, P. et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease. Nat. Genet. 43, 429–435 (2011). · DOI · Paper page
  27. Gao, Q., Wu, G. & Lai, K. W. C. Cholesterol modulates the formation of the Aβ ion channel in lipid bilayers. Biochemistry 59, 992–998 (2020). · DOI
  28. Lund, E. G., Guileyardo, J. M. & Russell, D. W. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc. Natl Acad. Sci. USA 96, 7238–7243 (1999). · DOI · Paper page
  29. Muffat, J. et al. Efficient derivation of microglia-like cells from human pluripotent stem cells. Nat. Med. 22, 1358–1367 (2016). · DOI · Paper page
  30. Abud, E. M. et al. iPSC-derived human microglia-like cells to study neurological diseases. Neuron 94, 278–293 (2017). e279. · DOI · Paper page
  31. Pandya, H. et al. Differentiation of human and murine induced pluripotent stem cells to microglia-like cells. Nat. Neurosci. 20, 753–759 (2017). · DOI · Paper page
  32. Song, L. et al. Functionalization of brain region-specific spheroids with isogenic microglia-like cells. Sci. Rep. 9, 11055 (2019). · DOI
  33. Xu, R. et al. Developing human pluripotent stem cell-based cerebral organoids with a controllable microglia ratio for modeling brain development and pathology. Stem Cell Rep. 16, 1923–1937 (2021). · DOI
  34. Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012). · DOI · Paper page
  35. Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888–1902 (2019). e1821. · DOI · Paper page
  36. Trapnell, C., Pachter, L. & Salzberg, S. L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105–1111 (2009). · DOI
  37. Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511–515 (2010). · DOI · Paper page
  38. Hassannia, B. et al. Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma. J. Clin. Investig. 128, 3341–3355 (2018). · DOI
  39. Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012). · DOI · Paper page
  40. Mancuso, R. et al. Stem-cell-derived human microglia transplanted in mouse brain to study human disease. Nat. Neurosci. 22, 2111–2116 (2019). · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Cakir, B., Tanaka, Y., Kiral, F. R., Xiang, Y., Dagliyan, O., Wang, J., Lee, M., Greaney, A. M., Yang, W. S., duBoulay, C., Kural, M. H., Patterson, B., Zhong, M., Kim, J., Bai, Y., Min, W., Niklason, L. E., Patra, P., & Park, I.-H.
Venue
Nature Communications
Published
2022-01-20
Volume
13
Issue
1
ISSN
2041-1723
Cited by
162
References
34
Language
en
Funders
  • U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (MH118344-01A1, MH118554-01A1)
  • U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (AA025080)
  • Center for Strategic Scientific Initiatives, National Cancer Institute (CA203011)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review